Trulieve Cannabis Corp. (TRLV) stock
TRLVNYSEMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/3033% below fair value
$10.07−0.26 (-2.52%)
Close on Nov 17, 2026Market cap $1.94BP/E –Yield –
Trulieve Cannabis total assets
Total assets on the balance sheet at the end of each period.
Trulieve Cannabis's total assets was $2.08B at Jun 30, 2026. For fiscal 2025 it was $2.70B, down 6.1% from the year before. The highest annual figure on record is $3.41B in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.70B | -6.1% |
| FY2024 | Dec 31, 2024 | $2.87B | +5.2% |
| FY2023 | Dec 31, 2023 | $2.73B | -19.7% |
| FY2022 | Dec 31, 2022 | $3.40B | -0.3% |
| FY2021 | Dec 31, 2021 | $3.41B | +321.2% |
| FY2020 | Dec 31, 2020 | $809.78M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $2.08B | -28.9% |
| Q1 FY2026 | Mar 31, 2026 | $2.78B | -3.7% |
| Q4 FY2025 | Dec 31, 2025 | $2.70B | -6.1% |
| Q3 FY2025 | Sep 30, 2025 | $2.94B | +2.3% |
| Q2 FY2025 | Jun 30, 2025 | $2.92B | +2.0% |
| Q1 FY2025 | Mar 31, 2025 | $2.89B | +2.4% |
| Q4 FY2024 | Dec 31, 2024 | $2.87B | +5.2% |
| Q3 FY2024 | Sep 30, 2024 | $2.87B | +3.6% |
| Q2 FY2024 | Jun 30, 2024 | $2.86B | +2.0% |
| Q1 FY2024 | Mar 31, 2024 | $2.82B | -15.0% |
| Q4 FY2023 | Dec 31, 2023 | $2.73B | -19.7% |
| Q3 FY2023 | Sep 30, 2023 | $2.78B | -16.4% |
| Q2 FY2023 | Jun 30, 2023 | $2.81B | -18.9% |
| Q1 FY2023 | Mar 31, 2023 | $3.32B | -5.9% |
| Q4 FY2022 | Dec 31, 2022 | $3.40B | -0.3% |
| Q3 FY2022 | Sep 30, 2022 | $3.32B | +160.3% |
| Q2 FY2022 | Jun 30, 2022 | $3.46B | +198.4% |
| Q1 FY2022 | Mar 31, 2022 | $3.53B | +290.9% |
| Q4 FY2021 | Dec 31, 2021 | $3.41B | +321.2% |
| Q3 FY2021 | Sep 30, 2021 | $1.28B | – |
| Q2 FY2021 | Jun 30, 2021 | $1.16B | – |
| Q1 FY2021 | Mar 31, 2021 | $902.09M | – |
| Q4 FY2020 | Dec 31, 2020 | $809.78M | – |
See a number that looks wrong?